2.19
2 yrs 10 m
1%
2,939.98 Crs
8.79
Mid Growth
SIP 100 & Lumpsum 100
sector funds
Nikhil Mathur
04-Oct-23
NA
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Investors understand that their principal will be at very high risk